GLP-1 medications to treat diabetes, obesity and several other illnesses have exploded in popularity since Ozempic was approved for use in Canada back in 2018. Ozempic and Wegovy, the GLP-1s which contain semaglutide, are the third-most prescribed drug in Canada and by far the bestselling one.
Chris Hannay, The Globe’s business of health reporter, will expl ... Show More
Aug 13
What it’s like to flee the B.C. wildfires
Summerland, B.C., has been devastated by the Bald Range wildfire. More than 20,000 people have evacuated, and by Wednesday, it had burned 178 square kilometres. The evacuees don’t know when they can return home yet, and many don’t know if their home is standing at all. Today, we ... Show More
32m 45s
Aug 12
Luluemon’s fight to stay on top of athleisure
For years, the Canadian athletic-wear brand Lululemon both pioneered and dominated the athleisure retail market. It turned workout gear into a status symbol, growing its international operations to 30 countries. But there’s trouble – a public battle with its founder, controversie ... Show More
25m 14s
Aug 11
Canadian banks are going big on AI
Canadian banks are leaning heavily into AI adoption. More than 30 per cent of finance and insurance firms are using AI, compared to just 1.5 per cent of businesses in accommodation and food services. The banks are spending millions, in some cases billions, of dollars on AI progra ... Show More
24m 41s